Taro Pharmaceutical Industries Ltd. (TAL.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:09AM CEST. Market open.
| Previous Close | 39.20 |
| Open | 39.40 |
| Bid | 0.00 x 20000 |
| Ask | 0.00 x 20000 |
| Day's Range | 39.40 - 39.40 |
| 52 Week Range | 30.80 - 39.80 |
| Volume | |
| Avg. Volume | 1 |
| Market Cap | 1.493B |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | 29.85 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 10, 2018 |
| 1y Target Est | N/A |
- PR Newswire
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associates referred as "Sun Pharma") and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders (including a vote of the majority of shares held by Taro shareholders unaffiliated with Sun Pharma) at an Extrao
- Business Wire
Taro Provides Results for Year Ended March 31, 2024
HAWTHORNE, N.Y., May 20, 2024--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024
- Business Wire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
NEW YORK, May 08, 2024--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
© 2024 Yahoo. All rights reserved.